We provide seamless end-to-end support, managing everything from high-fidelity sample processing and deep-sequencing to sophisticated bioinformatic modeling to ensure a cohesive biological narrative for your research.
Integrated Multi-Omics & Metastasis Risk Stratification Service
Creative Biolabs provides an end-to-end analytical framework that merges molecular sequencing with computational imaging. We offer researchers a unified platform to evaluate the metastatic potential of tumor models by observing the interplay between cellular genetics and environmental signals. By utilizing our service, clients gain a clear biological roadmap of dissemination pathways, enabling the identification of novel research targets and the optimization of experimental cohorts. Our goal is to provide the technical clarity needed to move high-potential research molecules forward with confidence.
Introduction What We Can Offer How We Can Help Why Choose Us Customer Reviews FAQs Related Services Contact Us
Introduction to Multi-Omics Metastasis Risk Stratification Service
Metastasis is a dynamic evolutionary process driven by genomic instability, exosomal signaling, and niche preparation. Traditional research scores often fail to capture the molecular heterogeneity of early progression. Our service addresses these gaps by fusing transcriptomic "signatures of aggression" with radiomic "phenotypes of spread." By identifying markers, we provide a validated framework for predicting the metastatic cascade with superior performance compared to unimodal approaches.
Request a Consultation →
Fig.1 Key processes in tumor progression and therapeutic resistance. 1
What We Can Offer
One-stop Integrated Multi-Omics Service
Customized Biomarker Panel Development
Our team designs bespoke panels targeting critical metastatic pathways like EMT or niche formation, allowing you to focus specifically on the biological mechanisms most relevant to your study.
Flexible "Multi-Modality" Selection
Tailor your project by selecting specific omics layers, such as transcriptomics or radiomics, allowing for a modular approach that aligns perfectly with your budgetary constraints and technical depth.
Site-Specific Metastasis Prediction
We offer specialized models optimized to forecast dissemination to high-incidence organs like the liver or CNS, providing deep insights into the organotropic behavior of your specific tumor models.
How Creative Biolabs Can Assist Your Project
Highlights
Leading Radiogenomic Expertise
Creative Biolabs leads the field in integrating radiological phenotypes with genomic data, providing a sophisticated analytical perspective that bridges the gap between imaging and molecular biology.
Unified Biological Narrative
Unlike competitors providing fragmented data silos, we synthesize multiple omics layers into a cohesive story, allowing you to see the full evolutionary trajectory of your models.
Robust Small-Cohort Processing
Our platform utilizes specialized data synthesis techniques to ensure statistically reliable results even for niche research cohorts with small sample sizes, maintaining high data integrity where traditional methods often fail.
Superior Noise Mitigation
By applying proprietary deep learning frameworks, we effectively filter technical artifacts and "noise," delivering high-fidelity insights that allow for the discovery of subtle metastatic signals.
Partnering with Creative Biolabs allows your organization to move beyond isolated data points and embrace a systems-level view of disease progression - Get a Quote Today.
Customer Reviews
-
Improved Progression Analysis
Using Creative Biolabs' service in our CRC research has improved our ability to distinguish between indolent and aggressive liver models, allowing us to focus our resources on high-risk clones. - Dr. A***n. L. -
Exosomal Insights
The exosomal RNA-Seq data provided a unique window into niche formation that we couldn't capture with standard methods. It facilitated our discovery of a new ligand-receptor pair in lung cancer research. - Prof. S***a. R.
FAQs
Can this service be used for rare tumor types with very few available samples?
Yes, we apply advanced CTGAN technologies to effectively augment datasets, ensuring statistically robust outcomes and reliable biological insights even when working with limited research cohorts.
Is the service compatible with archival samples?
Absolutely, our specialized extraction protocols are optimized to recover high-quality genomic data from aged or fragmented archival blocks, ensuring reliable results for retrospective research studies.
Related Services
Circulating Tumor Cell Enumeration & Molecular Profiling Service
We offer high-sensitivity detection and deep molecular characterization of rare circulating cells, providing a powerful liquid research tool for tracking real-time clonal evolution and metastatic dissemination patterns.
Learn More →Metastatic Colonization & Dormancy Modeling Service
We provide specialized analytical models to evaluate cellular quiescence and reactivation triggers in distant tissues, helping researchers understand the molecular mechanisms behind latent metastatic recurrence in various experimental systems.
Learn More →How to Contact Us
Creative Biolabs provides an advanced, end-to-end integrated platform for decoding the complexities of cancer metastasis. By combining high-fidelity molecular biology with state-of-the-art artificial intelligence, we offer a comprehensive solution to safeguard your research pipeline against data fragmentation and biological uncertainty.
Reach out to discuss how our multi-omics integration can be tailored to meet your specific research milestones - Get Started Today.
Reference
- Sabit, Hussein et al. "Leveraging Single-Cell Multi-Omics to Decode Tumor Microenvironment Diversity and Therapeutic Resistance." Pharmaceuticals (Basel, Switzerland) vol. 18,1 75. 10 Jan. 2025. Distributed under an Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/ph18010075
Download our brochureLoading case studies...
Online Inquiry